Navigation Links
Amicus Therapeutics Announces First Quarter 2008 Financial Results
Date:5/13/2008

tors presented positive results from Phase 2 clinical trials of Amigal at the American College of Medical Genetics (ACMG) meeting. The data showed that Amigal was generally safe and well-tolerated at all doses evaluated and no drug-related serious adverse events were reported. In addition, Amigal increased the level of the enzyme deficient in Fabry patients in 24 of 26 study subjects, and in a majority of study subjects the treatment resulted in a reduction of kidney GL-3 as measured in urine.

Amicus, along with its partner Shire, has initiated discussions with the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) regarding its plans for Phase 3 clinical evaluation of Amigal. Amicus expects to complete these interactions and provide an update in the second half of 2008, and subject to the outcome of the discussions, the Company plans to initiate the Phase 3 clinical trial in the first half of 2009.

In parallel with the regulatory process, 23 of the original 26 patients continue to be treated with Amigal in the voluntary Phase 2 extension study to monitor long term safety and efficacy. In addition, the Company will evaluate modified doses and dose regimens in these 23 patients. Data from this extension study are expected to be available by Q1 2009, prior to finalization of the Phase 3 protocol.

Gaucher Disease:

Plicera(TM) (isofagomine tartrate) is an investigational, oral therapeutic being developed for the treatment of Gaucher disease. At the ACMG meeting in March, clinical investigators presented full data from a 4 week Phase 2 study in Gaucher patients who switched from enzyme replacement therapy (ERT) with imiglucerase to the pharmacological chaperone Plicera. Results showed that Plicera was generally safe and well tolerated at all doses and increased target enzyme activity levels in a majority of patients. In the trial, GCase activity, as measured in white blood cells, was increased in 20 of the 26 pat
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Tenn. (PRWEB) July 29, 2014 ... in biomass feedstock supply innovation and supply chain ... proprietary feedstock management systems, Energy Grange™ and Supply ... of R&D and in-the-field testing aimed at consolidating ... offering benefits to landowners, farmers and feedstock end ...
(Date:7/29/2014)... 29, 2014 Quorum Review IRB, ... been awarded accreditation by the International Association ... Lean Six Sigma Deployment Program. The citation recognizes ... performance. , Quorum’s Lean Six Sigma program was ... Program designation. The designation is a public statement ...
(Date:7/29/2014)... 29, 2014 The first product launch ... generation approach to robotics. What sets Droidles completely apart ... technology that allows them to communicate, share code with ... the internet. , “The invention is the system,” said ... Droidles a life of their own, both physically and ...
(Date:7/29/2014)... Jason Wendel – recipient of a Regional Top Doctor Award ... Plastic Surgeon Specialists for Nashville, TN – has released a ... a Hydration Booster, Retexturing Night Crème, and Anti-aging C Complex, ... more radiant appearance while protecting them from the sun’s harmful ... at Dr. J. J. Wendel Plastic Surgery, we have developed ...
Breaking Biology Technology:Genera Energy Introduces Proprietary Feedstock Management Systems 2Genera Energy Introduces Proprietary Feedstock Management Systems 3Genera Energy Introduces Proprietary Feedstock Management Systems 4Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2Dr. J. J. Wendel Launches New Line of Skin Care Products 2
... have developed the first functional oxide thin films that ... to an array of new high-power devices and smart ... been able to produce positively charged (p-type) conduction and ... launching a new era in oxide electronics. To ...
... California, San Diego electrical engineers are building a forest of ... without using fossil fuels and harvest it for hydrogen fuel ... said nanowires, which are made from abundant natural materials like ... deliver hydrogen fuel on a mass scale. "This ...
... Eye Research Institute, a subsidiary of Mass. Eye and Ear ... first time that a bacterial pathogen can literally mow down ... and infect a part of the body. Their landmark study, ... , describes how they discovered that an "epidemic" strain ...
Cached Biology Technology:Functional oxide thin films create new field of oxide electronics 2Nanotrees harvest the sun's energy to turn water into hydrogen fuel 2Scientists Discover How a Bacterial Pathogen Breaks Down Barriers to Enter and Infect Cells 2Scientists Discover How a Bacterial Pathogen Breaks Down Barriers to Enter and Infect Cells 3
(Date:7/29/2014)... San Francisco is the first to show that while ... cellular aging, these negative effects may be reduced by ... , "The study participants who exercised, slept well and ... who didn,t maintain healthy lifestyles, even when they had ... PhD, assistant professor in the department of psychiatry at ...
(Date:7/28/2014)... people in the United States have a circulatory problem ... be painful and may even require surgery in serious ... wasting and, in turn, limb amputation. , At The ... Medical School, scientists tested a non-surgical preventative treatment in ... associated with increased blood circulation. Their proof-of-concept study ...
(Date:7/28/2014)... genome of Solanum pennellii , a wild relative ... international group of researchers including the labs headed by ... Davis Department of Plant Biology. The new genome information ... The work, published July 27 in the journal ... colleagues at Aachen University in Germany. The UC Davis ...
Breaking Biology News(10 mins):Healthy lifestyle may buffer against stress-related cell aging, study says 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2
... CHAPEL HILL, N.C. -- There has been controversy about ... about whether enough time has elapsed for life to have ... the University of North Carolina at Chapel Hill investigating the ... the time required for evolution on a warm earth is ...
... OH, December 2, 2010 -- Managing diabetes in a child ... Buying essential medical supplies, such as needles and testing strips, ... new study soon to be published in The Journal ... the financial burden of diabetes management increases a child,s risk ...
... December 1, 2010 The versatile organism Lactococcus ... into cheese, may also be valuable in the understanding ... biofuels. New research from Concordia University, published ... the bacterium can be engineered to transform plant material ...
Cached Biology News:Heat helped hasten life's beginnings 2New study calls for greater awareness of food supply for children with diabetes 2
... cells-directed transfection reagent : jetPEI-RGD ... which allows targeted efficient transfection ... cells. Integrins are adhesion molecules ... adhesion processes. Many integrins, including ...
... used on Macintosh operating systems to ... DNA sequence up to 3,200 bases, ... primers and GC clamps for mutation ... (DGGE), constant denaturing gel electrophoresis (CDGE), ...
... The Mini-Sub cell GT cell and PowerPac basic ... electrophoresis of nucleic acids in agarose gels. The ... lid with cables and electrodes, a 7 x ... two casting gates, and two 1.5 mm fixed-height ...
... top-of-the-line PowerPac 3000 power supply is ... ideal for isoelectric focusing, DNA sequencing, ... electrophoresis, western blotting, and submerged gel ... of powre, the PowerPac 3000 power ...
Biology Products: